IBDEI2B9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39203,1,3,0)
 ;;=3^Scleritis,Right Eye,Unspec
 ;;^UTILITY(U,$J,358.3,39203,1,4,0)
 ;;=4^H15.001
 ;;^UTILITY(U,$J,358.3,39203,2)
 ;;=^5004810
 ;;^UTILITY(U,$J,358.3,39204,0)
 ;;=H15.002^^153^1920^151
 ;;^UTILITY(U,$J,358.3,39204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39204,1,3,0)
 ;;=3^Scleritis,Left Eye,Unspec
 ;;^UTILITY(U,$J,358.3,39204,1,4,0)
 ;;=4^H15.002
 ;;^UTILITY(U,$J,358.3,39204,2)
 ;;=^5004811
 ;;^UTILITY(U,$J,358.3,39205,0)
 ;;=H57.00^^153^1920^5
 ;;^UTILITY(U,$J,358.3,39205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39205,1,3,0)
 ;;=3^Anomaly of Pupillary Function,Unspec
 ;;^UTILITY(U,$J,358.3,39205,1,4,0)
 ;;=4^H57.00
 ;;^UTILITY(U,$J,358.3,39205,2)
 ;;=^5006375
 ;;^UTILITY(U,$J,358.3,39206,0)
 ;;=H57.9^^153^1920^68
 ;;^UTILITY(U,$J,358.3,39206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39206,1,3,0)
 ;;=3^Eye and Adnexa Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,39206,1,4,0)
 ;;=4^H57.9
 ;;^UTILITY(U,$J,358.3,39206,2)
 ;;=^269333
 ;;^UTILITY(U,$J,358.3,39207,0)
 ;;=L10.9^^153^1920^126
 ;;^UTILITY(U,$J,358.3,39207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39207,1,3,0)
 ;;=3^Pemphigus,Unspec
 ;;^UTILITY(U,$J,358.3,39207,1,4,0)
 ;;=4^L10.9
 ;;^UTILITY(U,$J,358.3,39207,2)
 ;;=^5009090
 ;;^UTILITY(U,$J,358.3,39208,0)
 ;;=L10.81^^153^1920^124
 ;;^UTILITY(U,$J,358.3,39208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39208,1,3,0)
 ;;=3^Paraneoplastic Pemphigus
 ;;^UTILITY(U,$J,358.3,39208,1,4,0)
 ;;=4^L10.81
 ;;^UTILITY(U,$J,358.3,39208,2)
 ;;=^5009088
 ;;^UTILITY(U,$J,358.3,39209,0)
 ;;=L10.5^^153^1920^60
 ;;^UTILITY(U,$J,358.3,39209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39209,1,3,0)
 ;;=3^Drug-Induced Pemphigus
 ;;^UTILITY(U,$J,358.3,39209,1,4,0)
 ;;=4^L10.5
 ;;^UTILITY(U,$J,358.3,39209,2)
 ;;=^5009087
 ;;^UTILITY(U,$J,358.3,39210,0)
 ;;=L12.9^^153^1920^125
 ;;^UTILITY(U,$J,358.3,39210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39210,1,3,0)
 ;;=3^Pemphigoid,Unspec
 ;;^UTILITY(U,$J,358.3,39210,1,4,0)
 ;;=4^L12.9
 ;;^UTILITY(U,$J,358.3,39210,2)
 ;;=^5009102
 ;;^UTILITY(U,$J,358.3,39211,0)
 ;;=M35.01^^153^1920^153
 ;;^UTILITY(U,$J,358.3,39211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39211,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,39211,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,39211,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,39212,0)
 ;;=S05.01XA^^153^1920^89
 ;;^UTILITY(U,$J,358.3,39212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39212,1,3,0)
 ;;=3^Injury of Conjunctiva/Corneal Abrasion w/o FB,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,39212,1,4,0)
 ;;=4^S05.01XA
 ;;^UTILITY(U,$J,358.3,39212,2)
 ;;=^5020579
 ;;^UTILITY(U,$J,358.3,39213,0)
 ;;=S05.02XA^^153^1920^90
 ;;^UTILITY(U,$J,358.3,39213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39213,1,3,0)
 ;;=3^Injury of Conjunctiva/Corneal Abrasion w/o FB,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,39213,1,4,0)
 ;;=4^S05.02XA
 ;;^UTILITY(U,$J,358.3,39213,2)
 ;;=^5020582
 ;;^UTILITY(U,$J,358.3,39214,0)
 ;;=T15.02XA^^153^1920^69
 ;;^UTILITY(U,$J,358.3,39214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39214,1,3,0)
 ;;=3^FB in Cornea,Left Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,39214,1,4,0)
 ;;=4^T15.02XA
 ;;^UTILITY(U,$J,358.3,39214,2)
 ;;=^5046387
 ;;^UTILITY(U,$J,358.3,39215,0)
 ;;=T15.01XA^^153^1920^70
 ;;^UTILITY(U,$J,358.3,39215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39215,1,3,0)
 ;;=3^FB in Cornea,Right Eye,Init Encntr
 ;;^UTILITY(U,$J,358.3,39215,1,4,0)
 ;;=4^T15.01XA
 ;;^UTILITY(U,$J,358.3,39215,2)
 ;;=^5046384
